FDA Drug · D-0058-2025

Aspirin Chewable tablet 81 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-129-01

Class II · Ongoing

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Affected lots / codes — check yours against thisLot# 24A0061, exp. date 05/23/2026

Recalling firm: Safecor Health, LLC, Woburn, MA
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 1470 boxes
Distribution: USA nationwide.
Recall initiated: November 11, 2024
Classified: November 19, 2024
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0058-2025%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →